FDA Drug Application (202376) for RABEPRAZOLE SODIUM by TORRENT PHARMS LTD

Back to FDA Applications sponsored by TORRENT PHARMS LTD

Application Number202376
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRABEPRAZOLE SODIUM
Active IngredientRABEPRAZOLE SODIUM



Back to FDA Applications sponsored by TORRENT PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.